Find a Doctor

EB
Areas of Expertise

Dr. Emanuele Barbato

University Of Naples Federico II

Bio

Emanuele Barbato is in Naples, Italy. Dr. Barbato is a global expert in Stable Angina. They have been an author on 312 peer reviewed articles and participated in 2 clinical trials in the past 15 years. In particular, they have been an author on 33 peer reviewed articles and participated in 1 clinical trial regarding Stable Angina.

Areas of Expertise

Contact

Naples, 80131, IT

Latest Advances

  • Condition: Coronary Artery Disease
  • Journal: The New England journal of medicine
  • Treatment Used: P2Y12 Inhibitors vs. Ticagrelor vs. Prasugrel
  • Number of Patients: 2488
  • Published —
This study analyzed the effectiveness of P2Y12 Inhibitors (anti-platelet agents) versus Ticagrelor versus Prasugrel (blood thinners) in the treatment of patients undergoing primary percutaneous coronary intervention (PCI) with stent implantation (non-surgical procedure that uses a thin flexible tube to place a small structure called a stent to open up blood vessels).
  • Condition: Coronary Arteriosclerosis
  • Journal: European heart journal
  • Treatment Used: Fractional Flow Reserve-Guided Revascularization
  • Number of Patients: 1299
  • Published —
This study tested the safety and efficacy of using fractional flow reserve-guided revascularization to treat patients with coronary arteriosclerosis and reduced ejection fraction.
  • Condition: Long lesions
  • Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • Treatment Used: Bioresorbable vascular scaffolds or everolimus-eluting stents
  • Number of Patients: 66
  • Published —
The study researched the outcomes of bioresorbable vascular scaffolds or everolimus-eluting stents for patients with long lesions.
  • Condition: Multivessel coronary artery disease
  • Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • Treatment Used: Bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent
  • Number of Patients: 1119
  • Published —
The study compared the outcomes of bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent for patients with multivessel coronary artery disease.
  • Condition: Patients with Stable Coronary Lesions
  • Journal: European heart journal
  • Treatment Used: Fractional Flow Reserve-Guided Percutaneous Coronary Intervention (PCI) vs. Medical Therapy
  • Number of Patients: 2400
  • Published —
This review of the literature assessed the effect of fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) with contemporary drug-eluting stents on the composite of cardiac death or myocardial infarction (heart attack; MI) vs. medical therapy in patients with stable coronary lesions.
  • Condition: Coronary Artery Lesions
  • Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • Treatment Used: Drug Eluting Absorbable Metal Scaffold
  • Number of Patients: 184
  • Published —
In this study, researchers evaluated the safety and effectiveness of drug eluting absorbable metal scaffolds for the treatment of coronary artery lesions.
  • Condition: patients with ST-elevation myocardial infarction
  • Journal: Heart (British Cardiac Society)
  • Treatment Used: chronic total occlusion recanalization
  • Number of Patients: 302
  • Published —
The purpose of the study was to determine mid-term and long-term clinical outcome of concurrent chronic total occlusion percutaneous coronary intervention versus chronic total occlusion with no percutaneous coronary intervention in patients with ST-elevation myocardial infarction with concurrent chronic total occlusion.
  • Condition: Stable coronary artery disease
  • Journal: Circulation
  • Treatment Used: Percutaneous coronary intervention (PCI)
  • Number of Patients: 888
  • Published —
This study compared percutaneous coronary intervention (PCI) guided by fractional flow reserve with best medical therapy (MT) in patients with stable coronary artery disease.

Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 2000
  • Start Date: November 6, 2018
Comparison of Quantitative Flow Ratio (QFR) and Conventional Pressure-wire Based Functional Evaluation for Guiding Coronary Intervention. A Randomized Clinical Non-inferiority Trial
Clinical Trial
  • Status: Unknown status
  • Phase: Phase 4
  • Intervention Type: Procedure
  • Participants: 206
  • Start Date: March 2013
Graft Patency After FFR-guided Versus Angio-guided CABG: a Prospective, Multicenter, Multinational, Randomized (1:1) Controlled Trial

All Publications
View All

  • Journal: Circulation. Cardiovascular interventions
  • Published —
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis.
  • Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • Published —
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Contact

Naples, 80131, IT

Insurance

Contact them to find out if they accept your insurance plan.

Similar Doctors

GZ
Advanced
Giuseppe Gl Zoccai-Biondi
Naples, IT
0.1 km away
LD
Advanced
Luigi Di Serafino
Naples, IT
0.1 km away
GD
Advanced
Giuseppe Di Gioia
Naples, IT
0.1 km away
View All